Unlike cancersin which a few predominant oncogenic loci converge on a pathway, such asKRAS in PDAC or the mostly mutually exclusiveBRAF, NRAS, and NF1 inmelanoma, CCA is marked by a heterogeneous set of often-overlapping,lower-penetrance driver genes across diverse signaling pathways. This evidence concerns the gene NRAS and cholangiocarcinoma.